title: Effect of infliximab treatment on T cell cytokine responses in spondylarthropathy: comment on the article by Zou et al.
authors.forename: Dominique
authors.initials: D
authors.lastname: Baeten
authors.forename: Bernard
authors.initials: B
authors.lastname: Vandooren
authors.forename: Leen
authors.initials: L
authors.lastname: De Rycke
authors.forename: Eric M
authors.initials: EM
authors.lastname: Veys
authors.forename: Filip
authors.initials: F
authors.lastname: De Keyser
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D016207:Cytokines / Q000378:metabolism*; D006801:Humans; D000069285:Infliximab; D025242:Spondylarthropathies / Q000188:drug therapy* / Q000378:metabolism*; D013601:T-Lymphocytes / Q000378:metabolism*
chemical_list: D000911:Antibodies, Monoclonal; D016207:Cytokines; D000069285:Infliximab